Inhibition of influenza virus internalization by (-)-epigallocatechin-3- gallate

Antiviral Research

Volumn 100, Issue 2, 2013, Pages 460-472

  Kim, Meehyein ^a   Kim, So Yeon ^a   Lee, Hye Won ^a   Shin, Jin Soo ^a   Kim, Pilho ^a   Jung, Young Sik ^a   Jeong, Hyeong Seop ^b   Hyun, Jae Kyung ^b   Lee, Chong Kyo ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

( ) Epigallocatechin 3 gallate; Antiviral activity; Influenza virus; Membrane damage; Viral entry

Indexed keywords

EPIGALLOCATECHIN GALLATE; VIRUS SIALIDASE; ANTIVIRUS AGENT; CATECHIN; DRUG DERIVATIVE; ENZYME INHIBITOR; NA PROTEIN, INFLUENZA A VIRUS; SIALIDASE; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIVIRAL ACTIVITY; ARTICLE; CELL MEMBRANE; CHEMICAL STRUCTURE; INFLUENZA VIRUS; MDCK CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS REPLICATION; (-)-EPIGALLOCATECHIN-3-GALLATE; ANIMAL; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MEMBRANE DAMAGE; ORTHOMYXOVIRUS; PHYSIOLOGY;

ORTHOMYXOVIRIDAE;

(-)-EPIGALLOCATECHIN-3-GALLATE; ANTIVIRAL ACTIVITY; INFLUENZA VIRUS; MEMBRANE DAMAGE; VIRAL ENTRY;

ANIMALS; ANTIVIRAL AGENTS; CATECHIN; CELL LINE; ENZYME INHIBITORS; HUMANS; NEURAMINIDASE; ORTHOMYXOVIRIDAE; VIRAL PROTEINS; VIRUS INTERNALIZATION;

EID: 84885508832     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.08.002     Document Type: Article

References (32)

1. C. Cabrera, R. Artacho, and R. Gimenez Beneficial effects of green tea - a review J. Am. Coll. Nutr. 25 2006 79 99
2. N. Calland, A. Albecka, S. Belouzard, C. Wychowski, G. Duverlie, V. Descamps, D. Hober, J. Dubuisson, Y. Rouille, and K. Seron (-)-Epigallocatechin- 3-gallate is a new inhibitor of hepatitis C virus entry Hepatology 55 2012 720 729
3. C. Chen, H. Qiu, J. Gong, Q. Liu, H. Xiao, X.W. Chen, B.L. Sun, and R.G. Yang (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus Arch. Virol. 157 2012 1301 1312
4. E.J. Cho, S. Xia, L.C. Ma, J. Robertus, R.M. Krug, E.V. Anslyn, G.T. Montelione, and A.D. Ellington Identification of influenza virus inhibitors targeting NS1A utilizing fluorescence polarization-based high-throughput assay J. Biomol. Screen. 17 2012 448 459
5. S. Ciesek, T. von Hahn, C.C. Colpitts, L.M. Schang, M. Friesland, J. Steinmann, M.P. Manns, M. Ott, H. Wedemeyer, P. Meuleman, T. Pietschmann, and E. Steinmann The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry Hepatology 54 2011 1947 1955
6. E. De Clercq Antiviral agents active against influenza A viruses Nat. Rev. Drug Discov. 5 2006 1015 1025
7. K. Fujii, Y. Fujii, T. Noda, Y. Muramoto, T. Watanabe, A. Takada, H. Goto, T. Horimoto, and Y. Kawaoka Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions J. Virol. 79 2005 3766 3774
8. I. Hauber, H. Hohenberg, B. Holstermann, W. Hunstein, and J. Hauber The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection Proc. Natl. Acad. Sci. USA 106 2009 9033 9038
9. E. Hoffmann, G. Neumann, Y. Kawaoka, G. Hobom, and R.G. Webster A DNA transfection system for generation of influenza A virus from eight plasmids Proc. Natl. Acad. Sci. USA 97 2000 6108 6113
10. E. Hoffmann, J. Stech, Y. Guan, R.G. Webster, and D.R. Perez Universal primer set for the full-length amplification of all influenza A viruses Arch. Virol. 146 2001 2275 2289
11. A.C. Hurt, T. Chotpitayasunondh, N.J. Cox, R. Daniels, A.M. Fry, L.V. Gubareva, F.G. Hayden, D.S. Hui, O. Hungnes, A. Lackenby, W. Lim, A. Meijer, C. Penn, M. Tashiro, T.M. Uyeki, and M. Zambon Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives Lancet Infect. Dis. 12 2012 240 248
12. C.E. Isaacs, G.Y. Wen, W. Xu, J.H. Jia, L. Rohan, C. Corbo, V. Di Maggio, E.C. Jenkins Jr., and S. Hillier Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus Antimicrob. Agents Chemother. 52 2008 962 970
13. K. Kawai, N.H. Tsuno, J. Kitayama, Y. Okaji, K. Yazawa, M. Asakage, N. Hori, T. Watanabe, K. Takahashi, and H. Nagawa Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding J. Allergy Clin. Immunol. 112 2003 951 957
14. M.J. Kesic, S.O. Simmons, R. Bauer, and I. Jaspers Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells Free Radic. Biol. Med. 51 2011 444 453
15. M. Kim, J.H. Yim, S.Y. Kim, H.S. Kim, W.G. Lee, S.J. Kim, P.S. Kang, and C.K. Lee In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03 Antiviral Res. 93 2012 253 259
16. T. Kuzuhara, Y. Iwai, H. Takahashi, D. Hatakeyama, and N. Echigo Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase PLoS Curr. 1 2009 RRN1052
17. I.A. Leneva, R.J. Russell, Y.S. Boriskin, and A.J. Hay Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol Antiviral Res. 81 2009 132 140
18. S. Li, T. Hattori, and E.N. Kodama Epigallocatechin gallate inhibits the HIV reverse transcription step Antivir. Chem. Chemother. 21 2011 239 243
19. S.Y. Lyu, J.Y. Rhim, and W.B. Park Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro Arch. Pharm. Res. 28 2005 1293 1301
20. K.S. Matlin, H. Reggio, A. Helenius, and K. Simons Infectious entry pathway of influenza virus in a canine kidney cell line J. Cell Biol. 91 1981 601 613
21. J.L. McKimm-Breschkin Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance Influenza Other Respir. Viruses 7 Suppl. 1 2013 25 36
22. M. Nakayama, K. Suzuki, M. Toda, S. Okubo, Y. Hara, and T. Shimamura Inhibition of the infectivity of influenza virus by tea polyphenols Antiviral Res. 21 1993 289 299
23. M. Ohuchi, N. Asaoka, T. Sakai, and R. Ohuchi Roles of neuraminidase in the initial stage of influenza virus infection Microbes Infect. 8 2006 1287 1293
24. S. Pleschka, R. Jaskunas, O.G. Engelhardt, T. Zurcher, P. Palese, and A. Garcia-Sastre A plasmid-based reverse genetics system for influenza A virus J. Virol. 70 1996 4188 4192
25. D. Schols, R. Pauwels, F. Vanlangendonck, J. Balzarini, and E. De Clercq A highly reliable, sensitive, flow cytometric/fluorometric assay for the evaluation of the anti-HIV activity of antiviral compounds in MT-4 cells J. Immunol. Methods 114 1988 27 32
26. J.M. Song, K.H. Lee, and B.L. Seong Antiviral effect of catechins in green tea on influenza virus Antiviral Res. 68 2005 66 74
27. J.M. Song, K.D. Park, K.H. Lee, Y.H. Byun, J.H. Park, S.H. Kim, J.H. Kim, and B.L. Seong Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives Antiviral Res. 76 2007 178 185
28. Y. Sun, W.C. Hung, F.Y. Chen, C.C. Lee, and H.W. Huang Interaction of tea catechin (-)-epigallocatechin gallate with lipid bilayers Biophys. J. 96 2009 1026 1035
29. E. van der Vries, F.F. Stelma, and C.A. Boucher Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus N. Engl. J. Med. 363 2010 1381 1382
30. A. Wolkerstorfer, H. Kurz, N. Bachhofner, and O.H. Szolar Glycyrrhizin inhibits influenza A virus uptake into the cell Antiviral Res. 83 2009 171 178
31. C.S. Yang, P. Maliakal, and X. Meng Inhibition of carcinogenesis by tea Annu. Rev. Pharmacol. Toxicol. 42 2002 25 54
32. J.H. Yim, S.J. Kim, S.H. Ahn, and H.K. Lee Optimal conditions for the production of sulfated polysaccharide by marine microalga Gyrodinium impudicum strain KG03 Biomol. Eng. 20 2003 273 280